Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds ATBPF.
No tracked institution reports a position in ATBPF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2020-12-01 | 1-for-10reverse |
No one on the platform has traded ATBPF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $13M | +94.6% | $-0.47 | $-0.47–$-0.47 | — | 1 |
| 2028 | $17M | +26.3% | $-0.08 | $-0.08–$-0.08 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-02-14 | $-0.09 | $-0.06 | +33.3% |
| 2023-11-13 | $-0.09 | $-0.07 | +22.2% |
| 2023-08-14 | $-0.08 | $-0.08 | +0.0% |
| 2023-06-29 | $-0.07 | $-0.04 | +42.9% |
| 2023-02-15 | $-0.09 | $-0.06 | +33.3% |
| 2022-11-14 | $-0.08 | $-0.09 | -13.5% |
| 2022-08-15 | $-0.09 | $-0.08 | +11.1% |
| 2022-06-29 | $-0.16 | $-0.11 | +31.3% |
| $11M |
| — |
| LXXGFLexaGene Holdings Inc. | $0.08 | +0.00% | $11M | — |
| MGCLFMGC Pharmaceuticals Limited | $0.27 | +2.88% | $12M | — |
Source: Financial Modeling Prep · peers by sector/industry